NOCD launches parent brand Noto, acquires PTSD provider Rebound Health
NOCD, a provider of virtual therapy for obsessive-compulsive disorder, launched a new parent brand, Noto, on Tuesday to help expand into other virtual therapies. The company also announced on Tuesday the acquisition of Rebound Health, starting in the area of post-traumatic stress disorder.
Chicago-based NOCD actually connects people with OCD to therapists who specialize in exposure and response prevention therapy, a type of cognitive behavioral therapy created specifically for people with OCD. It works with payers and has a network of more than 1,000 therapists.
Noto, which means “to be known” in Latin, is an AI-driven platform that supports payer management functions such as member identification, enrollment, certification and revenue cycle management, while also enhancing patient engagement through targeted campaigns, community tools and live education events. On the clinical side, Noto provides therapists with AI training, clinical interview tools, documentation support, results tracking and ongoing supervision.
This technology has helped scale NOCD over the past decade, which is why the company chose to launch it as its parent brand to help expand specialty treatments for other complex mental and behavioral disorders.
Stephen Smith, CEO and founder of NOCD, said in an email: “Based on the impact Noto has brought to NOCD, we feel it is our responsibility to leverage Noto to expand other virtual specialties to address complex, hidden but highly treatable conditions, starting with Rebound for PTSD. …Imagine a world where 5+ specialties, including NOCD and Rebound, are powered by Noto, each leveraging operational support for payer partnerships, enrollment and treatment operations.”
Rebound Health will now operate as a dedicated specialty under Noto, just like NOCD. Rebound allows patients to meet regularly with a licensed trauma therapist via video conference, message the therapist between sessions, and perform guided exercises in between sessions.
The Rebound CEO said joining Noto provides the company with infrastructure for expansion.
“We founded Rebound to make trauma recovery the norm, not the exception. Survivors deserve access to specialized, evidence-based treatments to support true recovery, but for too long, this treatment simply hasn't existed at scale,” Rebound CEO and co-founder Raeva Kumar said in an email. “By joining Noto, we are able to accelerate our mission and bring proven trauma treatments to millions of survivors through its established infrastructure and technology-enabled platform.”
Rebound will continue to be led by Kumar and co-founder Dr. Erin Berenz.
By launching Noto and acquiring Rebound Health, Smith aims to “end the mental health crisis as we know it,” he said. The company plans to expand into more specialized areas in the future.
“Mental illnesses will never go away, but we can end their mismanagement by better diagnosing and treating each disorder at scale,” he said.
Photo: mikdam, Getty Images
